Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jan;63(1):76-84.
doi: 10.1128/JVI.63.1.76-84.1989.

Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element

A L Boral  1 , S A Okenquist, J Lenz
Affiliations

Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element

A L Boral et al. J Virol. 1989 Jan.

Abstract

Transient expression assays were used to determine the sequences within the long terminal repeat (LTR) that define the high activity in T-lymphoma cells of the leukemogenic SL3-3 virus in comparison with that of the nonleukemogenic Akv virus. Each of these viruses contains sequences related to the consensus element, the enhancer core. The SL3-3 and Akv enhancer cores differ at a single base pair. Substitution of the Akv core element into the SL3-3 LTR decreased expression in T-lymphoma cells but not in other cell types. Likewise, substitution of the SL3-3 core sequence into the Akv LTR increased expression in T-lymphoma cells but not in other types of hematopoietic cells. These data indicate that the SL3-3 enhancer core sequence functions better than that of Akv in T-lymphoma cells, but in other hematopoietic cell types the two are approximately equivalent. Competition DNA-protein binding assays were used to assess what nuclear factors from T-lymphoma lines and non-T lines bound to the SL3-3 and Akv core elements. Factors were detected that bound specifically to either the SL3-3 or Akv core but not to the other. Another factor was detected that bound equally well to both. However, none of these factors was specific to T-lymphoma cells.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. EMBO J. 1985 Jun;4(6):1609-14 - PubMed
    1. Mol Cell Biol. 1988 Apr;8(4):1625-37 - PubMed
    1. J Immunol. 1972 Oct;109(4):674-80 - PubMed
    1. J Immunol. 1973 Feb;110(2):431-8 - PubMed
    1. J Immunol. 1973 Jun;110(6):1470-5 - PubMed

Publication types